Profund Advisors LLC Dexcom Inc Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Dexcom Inc stock. As of the latest transaction made, Profund Advisors LLC holds 33,119 shares of DXCM stock, worth $2.66 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

33,119

Previous 34,972 5.3%

Holding current value

$2.66 Million

Previous $3.97 Million 44.04%

% of portfolio

0.09%

Previous 0.15%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $118,592 - $215,059	-1,853 Reduced 5.3%	33,119 $2.22 Million
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $72,363 - $92,135	656 Added 1.91%	34,972 $3.97 Million
Q1 2024 May 08, 2024	SELL	$114.22 - $140.1 $199,999 - $245,315	-1,751 Reduced 4.85%	34,316 $4.76 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $416,931 - $685,735	5,523 Added 18.08%	36,067 $4.48 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $618,341 - $991,027	7,185 Added 30.76%	30,544 $2.85 Million
Q2 2023 Aug 10, 2023	BUY	$112.47 - $130.98 $148,122 - $172,500	1,317 Added 5.97%	23,359 $3 Million
Q1 2023 May 11, 2023	SELL	$104.0 - $122.92 $87,464 - $103,375	-841 Reduced 3.68%	22,042 $2.56 Million
Q4 2022 Feb 02, 2023	SELL	$84.98 - $122.67 $125,430 - $181,060	-1,476 Reduced 6.06%	22,883 $2.59 Million
Q3 2022 Nov 04, 2022	SELL	$76.35 - $94.18 $123,992 - $152,948	-1,624 Reduced 6.25%	24,359 $1.96 Million
Q2 2022 Aug 01, 2022	BUY	$67.99 - $132.89 $1.24 Million - $2.43 Million	18,255 Added 236.22%	25,983 $1.94 Million
Q1 2022 May 10, 2022	SELL	$94.08 - $130.2 $254,580 - $352,321	-2,706 Reduced 25.93%	7,728 $3.95 Million
Q4 2021 Feb 08, 2022	SELL	$129.87 - $162.82 $26,103 - $32,726	-201 Reduced 1.89%	10,434 $5.6 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $86,968 - $116,691	815 Added 8.3%	10,635 $5.82 Million
Q2 2021 Aug 12, 2021	SELL	$80.99 - $107.93 $12,796 - $17,052	-158 Reduced 1.58%	9,820 $4.19 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $158,811 - $196,178	1,873 Added 23.11%	9,978 $3.59 Million
Q4 2020 Feb 09, 2021	BUY	$78.0 - $104.5 $22,308 - $29,887	286 Added 3.66%	8,105 $3 Million
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $2,387 - $2,823	-25 Reduced 0.32%	7,819 $3.22 Million
Q2 2020 Aug 03, 2020	BUY	$62.68 - $105.34 $420,645 - $706,936	6,711 Added 592.32%	7,844 $3.18 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $15,053 - $23,823	-315 Reduced 21.75%	1,133 $305,000
Q4 2019 Feb 18, 2020	BUY	$36.62 - $57.29 $53,025 - $82,955	1,448 New	1,448 $317,000
Q3 2019 Nov 12, 2019	SELL	$35.53 - $43.8 $52,690 - $64,955	-1,483 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$27.84 - $38.92 $22,132 - $30,941	-795 Reduced 34.9%	1,483 $222,000
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $4,743 - $6,452	169 Added 8.01%	2,278 $271,000
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $7,233 - $10,015	-268 Reduced 11.27%	2,109 $253,000
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $55,502 - $87,283	2,377 New	2,377 $340,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Dexcom Inc Transaction History